Steve Chatfield serves on the Scientific Advisory Board of Stablepharma Limited, focusing on innovative vaccine solutions. Additionally, Chatfield acts as Special Advisor for Healthcare Security at FIPRA International Limited, offering insights on health security and pandemic preparedness. As Non-Executive Director at The Precision Health Technologies Accelerator and Deputy Chairman at the Cell and Gene Therapy Catapult, Chatfield contributes to advancing health technology and biopharmaceutical development. In leadership roles at Prokarium and Savills, Chatfield supports cancer immunotherapy innovation and life sciences advisory. Previous advisory experience includes membership on the Scientific Advisory Board of Enesi Pharma Limited and serving as Interim CEO for the Vaccines Manufacturing and Innovation Centre. Chatfield has also advised the UK Vaccines Task Force during the urgent development of coronavirus vaccines. Academic background includes attendance at Chichester High School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices